Speech Therapy
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Governs coverage and clinical stance for speech therapy assessment, diagnosis, and treatment (including swallowing disorders) for Blue Cross Blue Shield - Rhode Island members; excludes services for autism and feeding disorders which are covered under separate policies.
No material clinical or coverage changes in this revision.
Coverage Criteria
Standard coverage
Speech therapy is covered when ALL of the following are met:
Applies to Medicare Advantage and Commercial products
Commercial products only
This policy is not applicable to speech services provided for members with a diagnosis of autism or for those with a feeding disorder. Such services are governed by separate, related policies and should be billed and authorized according to those specific policy provisions.
Group training sessions and educational speech programs (for example, the Hanen Program for Parents) are considered educational in nature and are not covered under this policy.
Fluency-enhancing or altered auditory feedback devices (examples include SpeechEasy, Fluency Master, Pocket Speech Lab, and the Basic Fluency System) used for treatment of stuttering are not supported as medically necessary due to insufficient evidence of long-term benefit and improved health outcomes; provision of these devices may be denied.
Coding
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder (includes aural rehabilitation); individual |
| 92508 | Treatment of speech, language, voice, communication, and/or auditory processing disorder (includes aural rehabilitation); group, two or more individuals |
| 92521 | Evaluation of speech fluency (e.g., stuttering, cluttering) |
| 92522 | Evaluation of speech sound production (e.g., articulation, phonological process, apraxia, dysarthria) |
| 92523 | Evaluation of speech sound production (e.g., articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (e.g., receptive and expressive language) |
| 92524 | Behavioral and qualitative analysis of voice and resonance |
| 92597 | Evaluation for use and/or fitting of voice prosthetic device to supplement oral speech |
| 92607 | Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; first hour |
| 92608 | Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; each additional 30 minutes (List separately in addition to code for primary procedure) |
| 92609 | Therapeutic services for the use of speech-generating device, including programming and modification |
Provider Actions & Requirements
Prior Authorization
Not applicable — prior authorization is not required for speech therapy per this policy.
Preferred Treatment Approach
Preferred treatment approach: Standard behavioral speech therapy provided by a qualified speech-language pathologist (SLP) is the supported treatment. Fluency-enhancing devices (e.g., SpeechEasy, Fluency Master, Pocket Speech Lab, Basic Fluency System) are considered not medically necessary due to insufficient evidence of long-term efficacy compared with standard speech therapy and therefore are not supported.
Provider Qualification & Documentation
Provider qualification and documentation: Services must be delivered by a qualified, licensed speech-language pathologist practicing within the scope of their license. Documentation must include an appropriate evaluation (e.g., codes 92521–92524, 92610–92611 as applicable), treatment plan, goals, frequency and duration of services, and progress notes supporting medical necessity.
- Document evaluation details (type, findings) and planned therapeutic interventions
- Include justification when services are provided in the home as part of home-care
- For children birth to 3 receiving Early Intervention Services (EIS), additional commercial coverage for speech therapy is not provided
Fluency Device Denial Risk
Denial risk: Fluency-enhancing (stuttering) devices are considered not medically necessary and are subject to denial.
- Examples: SpeechEasy, Fluency Master, Pocket Speech Lab, Basic Fluency System — use of these devices may be denied
- Rationale: Insufficient high-quality evidence demonstrating long-term benefit over standard speech therapy
Background
Speech therapy encompasses assessment, diagnosis, and rehabilitation for communication impairments and swallowing disorders and is intended to facilitate the development and maintenance of communication and safe swallowing.
Services typically include comprehensive evaluation of speech, language, voice, fluency, and swallowing function, followed by individualized treatment planning and therapeutic interventions delivered by a qualified, licensed speech-language pathologist.
Treatment modalities range from behavioral speech-language therapy to instrumental assessments (for example, motion fluoroscopic studies of swallowing). Altered auditory feedback (AAF) approaches — including delayed (DAF), frequency-shifted (FAF), and masking (MAF) feedback — have been proposed to reduce stuttering by recreating the choral effect, but the underlying mechanisms are not established and the clinical evidence for long-term efficacy is limited.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.